Geometry−Affinity Relationships of the Selective Serotonin Receptor Ligand 9-(Aminomethyl)-9,10-dihydroanthracene

Journal of Medicinal Chemistry
2002.0

Abstract

With the exception of its two aromatic rings and basic nitrogen atom, 9-(aminomethyl)-9,10-dihydroanthracene (AMDA; 1) is remarkably devoid of the pharmacophore features usually associated with high-affinity receptor ligands such as the heteroatom hydrogen bonding features of the endogenous ligand serotonin. AMDA does contain a phenylethylamine skeleton within a tricyclic ring system, and the presence of the second aromatic group is necessary for optimal receptor affinity. The structural requirements for the binding of AMDA at 5-HT(2A) receptors were investigated with respect to the geometric relationship between the two aromatic rings. It appears that the geometry of the AMDA parent is in the optimal range for fold angle between aromatic moieties. Evaluation of conformationally constrained derivatives of AMDA suggests that a chain extended trans, gauche form is most likely responsible for high affinity.

Knowledge Graph

Similar Paper

Geometry−Affinity Relationships of the Selective Serotonin Receptor Ligand 9-(Aminomethyl)-9,10-dihydroanthracene
Journal of Medicinal Chemistry 2002.0
Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene
Bioorganic & Medicinal Chemistry Letters 2001.0
Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor
Bioorganic & Medicinal Chemistry Letters 2001.0
Potential Modes of Interaction of 9-Aminomethyl-9,10-dihydroanthracene (AMDA) Derivatives with the 5-HT<sub>2A</sub>Receptor: A Ligand Structure-Affinity Relationship, Receptor Mutagenesis and Receptor Modeling Investigation
Journal of Medicinal Chemistry 2008.0
Structural determinants for high 5-HT 2A receptor affinity of spiro[9,10-dihydroanthracene]-9,3 ′ -pyrrolidine (SpAMDA)
Bioorganic &amp; Medicinal Chemistry Letters 2004.0
Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT<sub>2A/2C</sub> Receptor Ligands
Journal of Medicinal Chemistry 2003.0
Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor
Journal of Medicinal Chemistry 1988.0
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity
Journal of Medicinal Chemistry 2004.0
Influence of Amine Substituents on 5-HT2A versus 5-HT2C Binding of Phenylalkyl- and Indolylalkylamines
Journal of Medicinal Chemistry 1994.0
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT<sub>2A</sub>Partial Agonists
Journal of Medicinal Chemistry 2000.0